摘要
乙肝肝硬化是我国常见疾病,本文对其流行病学进行了总结,分析了造成乙肝肝硬化生存预后不良的危险因素,阐述中医药改善乙肝肝硬化患者生存预后的理论基础,总结整理中药方剂、中药单药影响乙肝肝硬化患者生存预后因素的研究进展,阐明中医药改善生存预后的作用。
Hepatitis B cirrhosis is a common disease in China. This paper summarized its epidemiology, analyzed the risk factors causing poor survival prognosis of hepatitis B cirrhosis, expounded the theoretical basis of TCM improving survival and prognosis of patients with hepatitis B cirrhosis, summarized the research progress of Chinese medicine prescription and herb affecting survival prognosis of patients with hepatitis B cirrhosis to clarify the effect of TCM on improving survival and prognosis.
出处
《临床医学进展》
2022年第3期2160-2164,共5页
Advances in Clinical Medicine